Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Crossref DOI link: https://doi.org/10.1186/s13058-017-0900-z
Published Online: 2017-10-03
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baldassarre, Tomas
Truesdell, Peter
Craig, Andrew W.
Funding for this research was provided by:
Canadian Institutes of Health Research (119562)
Cancer Research Society
